TardiMed Sciences LLC, 10% Owner at Timber Pharmaceuticals, Inc. (TMBR), sold 375,963 shares at $1.03 ($387K) on 2020-09-16, disclosed to the SEC on 2020-09-16.
Open-market sale of $387k TMBR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.03 | 455 | $469 | 0.1% |
| 2 | $1.03 | 87,060 | $90K | 23.2% |
| 3 | $1.03 | 87,060 | $90K | 23.2% |
| 4 | $1.03 | 100,694 | $104K | 26.8% |
| 5 | $1.03 | 100,694 | $104K | 26.8% |
| Total | $1.03 avg | 375,963 |
| $387K |
| 100% |
| Filing → |
| TMBR | SELL | 2021-09-01 | $368K | — | Filing → |
| TMBR | SELL | 2021-08-26 | $276K | — | Filing → |
| TMBR | SELL | 2021-08-20 | $168K | — | Filing → |